A study of the association between seasonal influenza vaccines and the increased risk of Guillain-Barré syndrome using Vaccine Adverse Event Reporting System, 2018-2019.

Fujimori, M; Hasegawa, S; Sasaoka, S; Iguchi, K; Nakamura, M

Fujimori, M; Hasegawa, S; Sasaoka, S; Iguchi, K; Nakamura, M.

Affiliation

Fujimori M; General Affairs Team, Marumori-machi National Health Insurance Marumori Hospital, Miyagi, Japan;, Email: m-fujimori@town.marumori.miyagi.jp.
Hasegawa S; Laboratory of Drug informatics, Gifu Pharmaceutical University, Japan.
Sasaoka S; Laboratory of Drug informatics, Gifu Pharmaceutical University, Japan.
Iguchi K; Laboratory of Community Pharmacy, Gifu Pharmaceutical University, Gifu, Japan.
Nakamura M; Laboratory of Drug informatics, Gifu Pharmaceutical University, Japan.

Pharmazie ; 76(9): 437-443, 2021 09 01.

Article in En | MEDLINE | ID: mdl-34481535

Subject(s)

Guillain-Barre Syndrome; Influenza Vaccines; Female; Guillain-Barre Syndrome/chemically induced; Guillain-Barre Syndrome/epidemiology; Humans; Incidence; Influenza Vaccines/adverse effects; Male; Seasons; United States/epidemiology; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Influenza Vaccines / Guillain-Barre Syndrome Type of study: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: America do norte Language: En Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google